| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |